Literature DB >> 12529378

A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical.

Kaushik Biswas1, Uday Bandyopadhyay, Ishita Chattopadhyay, Archana Varadaraj, Esahak Ali, Ranajit K Banerjee.   

Abstract

The mechanism of the antiulcer effect of omeprazole was studied placing emphasis on its role to block oxidative damage and apoptosis during ulceration. Dose-response studies on gastroprotection in stress and indomethacin-induced ulcer and inhibition of pylorus ligation-induced acid secretion indicate that omeprazole significantly blocks gastric lesions at lower dose (2.5 mg/kg) without inhibiting acid secretion, suggesting an independent mechanism for its antiulcer effect. Time course studies on gastroprotection and acid reduction also indicate that omeprazole almost completely blocks lesions at 1 h when acid inhibition is partial. The severity of lesions correlates well with the increased level of endogenous hydroxyl radical (*OH), which when scavenged by dimethyl sulfoxide causes around 90% reduction of the lesions, indicating that *OH plays a major role in gastric damage. Omeprazole blocks stress-induced increased generation of *OH and associated lipid peroxidation and protein oxidation, indicating that its antioxidant role plays a major part in preventing oxidative damage. Omeprazole also prevents stress-induced DNA fragmentation, suggesting its antiapoptotic role to block cell death during ulceration. The oxidative damage of DNA by *OH generated in vitro is also protected by omeprazole or its analogue, lansoprazole. Lansoprazole when incubated in a *OH-generating system scavenges *OH to produce four oxidation products of which the major one in mass spectroscopy shows a molecular ion peak at m/z 385, which is 16 mass units higher than that of lansoprazole (m/z 369). The product shows no additional aromatic proton signal for aromatic hydroxylation in (1)H NMR. The product absorbing at 278 nm shows no alkaline shift for phenols, thereby excluding the formation of hydroxylansoprazole. The product is assigned to lansoprazole sulfone formed by the addition of one oxygen atom at the sulfur center following attack by the *OH. Thus, omeprazole plays a significant role in gastroprotection by acting as a potent antioxidant and antiapoptotic molecule.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529378     DOI: 10.1074/jbc.M210328200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  101 in total

1.  A prospective randomized controlled trial of omeprazole for preventing esophageal stricture in grade 2b and 3a corrosive esophageal injuries.

Authors:  Prasit Mahawongkajit; Prakitpunthu Tomtitchong; Nuttorn Boochangkool; Chatchai Mingmalairak; Surajit Awsakulsutthi; Chittinad Havanond
Journal:  Surg Endosc       Date:  2020-06-15       Impact factor: 4.584

Review 2.  Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond.

Authors:  Jan C Becker; Wolfram Domschke; Thorsten Pohle
Journal:  Br J Clin Pharmacol       Date:  2004-12       Impact factor: 4.335

3.  Risk Factors for Esophageal Stricture in Grade 2b and 3a Corrosive Esophageal Injuries.

Authors:  Prasit Mahawongkajit; Prakitpunthu Tomtitchong; Nuttorn Boochangkool; Palin Limpavitayaporn; Amonpon Kanlerd; Chatchai Mingmalairak; Surajit Awsakulsutthi; Chittinad Havanond
Journal:  J Gastrointest Surg       Date:  2018-05-31       Impact factor: 3.452

4.  Effects of esomeprazole magnesium on nonsteroidal anti-inflammatory drug gastropathy.

Authors:  Timothy R Koch; Ann Petro; Marcus Darrabie; Emmanuel C Opara
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

Review 5.  Present status and strategy of NSAIDs-induced small bowel injury.

Authors:  Kazuhide Higuchi; Eiji Umegaki; Toshio Watanabe; Yukiko Yoda; Eijiro Morita; Mitsuyuki Murano; Satoshi Tokioka; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-07-01       Impact factor: 7.527

6.  Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/ reoxygenation induced intestinal injury in newborn rats.

Authors:  Unal Biçakçi; Burak Tander; Ender Aritürk; Birsen Kiliçoğlu Aydin; Oğuz Aydin; Riza Rizalar; Zafer Eren; Ferit Bernay
Journal:  Pediatr Surg Int       Date:  2005-10-21       Impact factor: 1.827

7.  Protective effects of D-002 on experimentally induced gastroesophageal reflux in rats.

Authors:  Zullyt Zamora; Vivian Molina; Rosa Mas; Yazmin Ravelo; Yohany Perez; Ambar Oyarzabal
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

8.  Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart Jon Spechler
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

9.  Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats.

Authors:  Hiroshi Ichikawa; Norimasa Yoshida; Tomohisa Takagi; Naoya Tomatsuri; Kazuhiro Katada; Yutaka Isozaki; Kazuhiko Uchiyama; Yuji Naito; Takeshi Okanoue; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

10.  Effects of pantoprazole on ulcer healing delay associated with NSAID treatment.

Authors:  Matteo Fornai; Rocchina Colucci; Luca Antonioli; Narcisa Ghisu; Marco Tuccori; Corrado Blandizzi; Mario Del Tacca
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-14       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.